Антигенні властивості фібриногензв'язуючих білків та їхня роль у патогенезі стафілококових інфекцій. Зовнішньоклітинні фібриногензв'язуючі білки

Автор(и)

  • В. Д. Іванова Київський національний університет імені Тараса Шевченка вул. Володимирська 64, Київ, Україна, 01033 Автор
  • В. К. Позур Київський національний університет імені Тараса Шевченка вул. Володимирська 64, Київ, Україна, 01033 Автор

DOI:

https://doi.org/10.7124/bc.00060A

Анотація

Staphylococcus aureus продукує три зовнішньоклітинних фібриногензв'язуючих білки – коагулазу (Соа), білок адгезії (Еар) та зовніиіньоклітинний фібриногензв'язуючий білок (Efb), які ві діграють важливу роль у розвитку та протіканні стафілококових інфекцій. Імунізація деякими з цих білків захищає тварин від інфікування. В даному огляді розглянуто структуру, особливості взаємодії з фібриногеном та біологічні властивості зовніиіньоклітинних білків S. aureus

Посилання

Bod?n MK, Flock JI. Fibrinogen-binding protein/clumping factor from Staphylococcus aureus. Infect Immun. 1989;57(8):2358-63.

Phonimdaeng P, O'Reilly M, Nowlan P, Bramley AJ, Foster TJ. The coagulase of Staphylococcus aureus 8325-4. Sequence analysis and virulence of site-specific coagulase-deficient mutants. Mol Microbiol. 1990;4(3):393-404.

Dickinson RB, Nagel JA, McDevitt D, Foster TJ, Proctor RA, Cooper SL. Quantitative comparison of clumping factor- and coagulase-mediated Staphylococcus aureus adhesion to surface-bound fibrinogen under flow. Infect Immun. 1995;63(8):3143-50.

Hemker HC, Bas BM, Muller AD. Activation of a pro-enzyme by a stoichiometric reaction with another protein. The reaction between prothrombin and staphylocoagulase. Biochim Biophys Acta. 1975;379(1):180-8.

Jeljaszewicz J. Staphylocoagulase and clumping factor. Staphylococci and staphylococcal infections. Eds C. S. F. Easmon, C. Adlan. London: Acad, press, 1983. Vol. 2: 525-43.

Ushioda H, Terayama T, Sakai S, Zen-Yoji H, Nishiwaki M, Hidano A. Coagulase typing of Staphylococcus aureus and its application in routine work. Staphylococci and staphylococcal diseases. Ed. J. Jeljaszewicz. Stuttgart: Gustav Fisher, 1981. Suppl. 10: 77-83.

Kaida S, Miyata T, Yoshizawa Y, Igarashi H, Iwanaga S. Nucleotide and deduced amino acid sequences of staphylocoagulase gene from Staphylococcus aureus strain 213. Nucleic Acids Res. 1989;17(21):8871.

Kaida S, Miyata T, Yoshizawa Y, Kawabata S, Morita T, Igarashi H, Iwanaga S. Nucleotide sequence of the staphylocoagulase gene: its unique COOH-terminal 8 tandem repeats. J Biochem. 1987;102(5):1177-86.

McDevitt D, Vaudaux P, Foster TJ. Genetic evidence that bound coagulase of Staphylococcus aureus is not clumping factor. Infect Immun. 1992;60(4):1514-23.

Raus J, Love DN. Comparison of the affinities to bovine and human prothrombin of the staphylocoagulases from Staphylococcus intermedius and Staphylococcus aureus of animal origin. J Clin Microbiol. 1991;29(3):570-2.

Jeljaszewicz J. Staphylocoagulase and clumping factor. Action in vivo II Staphylococci and staphylococcal infections. Eds C. S. F. Easmon, C. Adlan. London: Acad, press, 1983. Vol. 2: 543-4.

Hasegawa N, San Clemente CL. Virulence and immunity of Staphylococcus aureus BB and certain deficient mutants. Infect Immun. 1978;22(2):473-9.

Jonsson P, Lindberg M, Haraldsson I, Wadstr?m T. Virulence of Staphylococcus aureus in a mouse mastitis model: studies of alpha hemolysin, coagulase, and protein A as possible virulence determinants with protoplast fusion and gene cloning. Infect Immun. 1985;49(3):765-9.

Seki K, Ogasawara M, Sakurada J, Murai M, Masuda S. Altered virulence of a pleiotropic Staphylococcus aureus mutant with a low producibility of coagulase and other factors in mice. Microbiol Immunol. 1989;33(12):981-90.

Cawdery M, Foster WD, Hawgood BC, Taylor C. The role of coagulase in the defence of Staphylococcus aureus against phagocytosis. Br J Exp Pathol. 1969;50(4):408-12.

Baddour LM, Tayidi MM, Walker E, McDevitt D, Foster TJ. Virulence of coagulase-deficient mutants of Staphylococcus aureus in experimental endocarditis. J Med Microbiol. 1994;41(4):259-63.

Moreillon P, Entenza JM, Francioli P, McDevitt D, Foster TJ, Fran?ois P, Vaudaux P. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun. 1995;63(12):4738-43.

Sawai T, Tomono K, Yanagihara K, Yamamoto Y, Kaku M, Hirakata Y, Koga H, Tashiro T, Kohno S. Role of coagulase in a murine model of hematogenous pulmonary infection induced by intravenous injection of Staphylococcus aureus enmeshed in agar beads. Infect Immun. 1997;65(2):466-71.

Mamo W, Bod?n M, Flock JI. Vaccination with Staphylococcus aureus fibrinogen binding proteins (FgBPs) reduces colonisation of S. aureus in a mouse mastitis model. FEMS Immunol Med Microbiol. 1994;10(1):47-53.

Bod?n MK, Flock JI. Evidence for three different fibrinogen-binding proteins with unique properties from Staphylococcus aureus strain Newman. Microb Pathog. 1992;12(4):289-98.

Palma M, Haggar A, Flock JI. Adherence of Staphylococcus aureus is enhanced by an endogenous secreted protein with broad binding activity. J Bacteriol. 1999;181(9):2840-5.

McGavin MH, Krajewska-Pietrasik D, Ryd?n C, H??k M. Identification of a Staphylococcus aureus extracellular matrix-binding protein with broad specificity. Infect Immun. 1993;61(6):2479-85.

H?ltje JV, Tomasz A. Specific recognition of choline residues in the cell wall teichoic acid by the N-acetylmuramyl-L-alanine amidase of Pneumococcus. J Biol Chem. 1975;250(15):6072-6.

Braun L, Dramsi S, Dehoux P, Bierne H, Lindahl G, Cossart P. InlB: an invasion protein of Listeria monocytogenes with a novel type of surface association. Mol Microbiol. 1997;25(2):285-94.

Palma M, Wade D, Flock M, Flock JI. Multiple binding sites in the interaction between an extracellular fibrinogen-binding protein from Staphylococcus aureus and fibrinogen. J Biol Chem. 1998;273(21):13177-81.

Bod?n W?stfelt MK, Flock JI. Incidence of the highly conserved fib gene and expression of the fibrinogen-binding (Fib) protein among clinical isolates of Staphylococcus aureus. J Clin Microbiol. 1995;33(9):2347-52.

Novick RP, Ross HF, Projan SJ, Kornblum J, Kreiswirth B, Moghazeh S. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J. 1993;12(10):3967-75.

Horstmann RD, Sievertsen HJ, Leippe M, Fischetti VA. Role of fibrinogen in complement inhibition by streptococcal M protein. Infect Immun. 1992;60(12):5036-41.

Bod?n MK, Flock JI. Cloning and characterization of a gene for a 19 kDa fibrinogen-binding protein from Staphylococcus aureus. Mol Microbiol. 1994;12(4):599-606.

Switalski L M. Isolation and purification of staphylococcal clumping factor. Staphylococci and staphylococcal diseases. Ed. J. Jeljaszewicz. Stuttgart: Gustav Fisher, 1976: 413-25.

Wade D, Palma M, L?fving-Arvholm I, S?llberg M, Silberring J, Flock JI. Identification of functional domains in Efb, a fibrinogen binding protein of Staphylococcus aureus. Biochem Biophys Res Commun. 1998;248(3):690-5.

Palma M, Nozohoor S, Schennings T, Heimdahl A, Flock JI. Lack of the extracellular 19-kilodalton fibrinogen-binding protein from Staphylococcus aureus decreases virulence in experimental wound infection. Infect Immun. 1996;64(12):5284-9.

Colque-Navarro P, Palma M, S?derquist B, Flock JI, M?llby R. Antibody responses in patients with staphylococcal septicemia against two Staphylococcus aureus fibrinogen binding proteins: clumping factor and an extracellular fibrinogen binding protein. Clin Diagn Lab Immunol. 2000;7(1):14-20.

Завантаження

Опубліковано

2002-07-20

Номер

Розділ

Огляди